Surrozen, Inc./DE Shares Repurchased
Surrozen, Inc./DE (SRZN) had Shares Repurchased of 400.00 thousand shares as of 2022-12-12, per its 10-K filed 2024-04-10.
Discontinued › Shareholders' Equity
us-gaap:StockRepurchasedDuringPeriodShares · last filed 2024-04-10
- 2022-12-12: Stock Repurchased During Period, Shares 400.00K shares; Stock Repurchased During Period, Shares as first filed 5.40M shares.
| Period end | Stock Repurchased During Period, Shares | Stock Repurchased During Period, Shares as first filed |
|---|---|---|
| 2022-12-12 | 400.00K shares 10-K · filed 2024-04-10 | 5.40M shares 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |